Cargando…

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

Recombinant protein approaches offer major promise for safe and effective vaccine prevention of SARS-CoV-2 infection. We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibody and T-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabynov, Kairat, Turebekov, Nurkeldi, Babayeva, Meruert, Fomin, Gleb, Yerubayev, Toktassyn, Yespolov, Tlektes, Li, Lei, Renukaradhya, Gourapura J., Petrovsky, Nikolai, Tabynov, Kaissar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866462/ https://www.ncbi.nlm.nih.gov/pubmed/35197485 http://dx.doi.org/10.1038/s41541-022-00450-8

Ejemplares similares

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
por: Tabynov, Kairat, et al.
Publicado: (2022)

An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
por: Babayeva, Meruert, et al.
Publicado: (2022)

Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model
por: Tabynov, Kairat, et al.
Publicado: (2022)

Cytokine response and damages in the lungs of aging Syrian hamsters on a high-fat diet infected with the SARS-CoV-2 virus
por: Fomin, Gleb, et al.
Publicado: (2023)

Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets
por: Tabynov, Kairat, et al.
Publicado: (2016)

Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
por: Ryskeldinova, Sholpan, et al.
Publicado: (2021)

Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats
por: Mailybayeva, Aigerim, et al.
Publicado: (2017)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
por: Mailybayeva, Aigerim, et al.
Publicado: (2020)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

Operationalizing Cooperative Research for Infectious Disease Surveillance: Lessons Learned and Ways Forward
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
por: Zhugunissov, Kuandyk, et al.
Publicado: (2021)

The pathogenicity of swan derived H5N1 virus in birds and mammals and its gene analysis
por: Tabynov, Kairat, et al.
Publicado: (2014)

Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs
por: Bugybayeva, Dina, et al.
Publicado: (2020)

Cooperative Research and Infectious Disease Surveillance: A 2021 Epilogue
por: Parekh, Falgunee K., et al.
Publicado: (2022)

A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model
por: Bugybayeva, Dina, et al.
Publicado: (2021)

Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages
por: Zhang, Lu, et al.
Publicado: (2021)

A Case History in Cooperative Biological Research: Compendium of Studies and Program Analyses in Kazakhstan
por: Yeh, Kenneth B., et al.
Publicado: (2019)

Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives
por: Patil, Veerupaxagouda, et al.
Publicado: (2022)

Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry
por: Renu, Sankar, et al.
Publicado: (2018)

Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens
por: Renu, Sankar, et al.
Publicado: (2020)

Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
por: Khosa, Celso, et al.
Publicado: (2017)

Immune Response to Salmonella Enteritidis Infection in Broilers Immunized Orally With Chitosan-Based Salmonella Subunit Nanoparticle Vaccine
por: Han, Yi, et al.
Publicado: (2020)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Chitosan Nanoparticle Based Mucosal Vaccines Delivered Against Infectious Diseases of Poultry and Pigs
por: Renu, Sankar, et al.
Publicado: (2020)

Nanoparticle-based vaccine development and evaluation against viral infections in pigs
por: Dhakal, Santosh, et al.
Publicado: (2019)

An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination
por: Binjawadagi, Basavaraj, et al.
Publicado: (2014)

Mannose-Modified Chitosan-Nanoparticle-Based Salmonella Subunit OralVaccine-Induced Immune Response and Efficacy in a Challenge Trial in Broilers
por: Han, Yi, et al.
Publicado: (2020)

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection
por: Tabynov, Kaissar, et al.
Publicado: (2014)

Building Scientific Capability and Reducing Biological Threats: The Effect of Three Cooperative Bio-Research Programs in Kazakhstan
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant
por: Dwivedi, Varun, et al.
Publicado: (2011)

Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation
por: Renukaradhya, Gourapura J., et al.
Publicado: (2015)

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs
por: Thomas, Milton, et al.
Publicado: (2015)

Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs
por: Binjawadagi, Basavaraj, et al.
Publicado: (2014)

PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs
por: Dwivedi, Varun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fsaodpv3hks7omekidft5es34f